In the News

A mother and daughter are seated at a table and a doctor is seated across from them.
April 29, 2021
The Association for Accessible Medicines (AAM) and its Biosimilars Council are pleased to offer our support and endorsement of The Increasing Access to Biosimilars Act.
The White House - Washington DC, United States
April 26, 2021
The Advancing Education on Biosimilars Act of 2021 authorizes the Food and Drug Administration to educate consumers and health care providers on the benefits of biosimilar medications.
Doctor meets with diabetic senior woman at medical appointment
April 23, 2021
The Biosimilars Council strongly supports the reintroduction, and encourages swift passage, of the bipartisan BIOSIM Act (HR 2815).
March 25, 2021
AAM and its Biosimilars Council urge Congress and CMS to align Medicare payment policies to favor use of lower-cost biosimilars.
aam policy agenda 117th congress
February 22, 2021
The Association for Accessible Medicines (AAM) and its Biosimilars Council shared their policy priorities for the Biden administration and 117th Congress, highlighting solutions to maintain the sustainability of generic and biosimilar competition.
part d statement
January 15, 2021
AAM and its Biosimilars Council applaud the decision by CMS to update the Part D program and allow plans with lower cost-sharing.

Recent Tweets